Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.06 EUR
709.08 M EUR
3.62 B EUR
220.46 M
About Hologic, Inc.
Sector
Industry
CEO
Stephen P. MacMillan
Website
Headquarters
Marlborough
Founded
1985
ISIN
US4364401012
FIGI
BBG00FZMF7G0
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Related stocks
Hologic, Inc. - [HOLX]Trend Analysis :
Current Price: $81.24.
Recent Trend: The price has been in an uptrend from mid-June 2024 after a decline from the high in early May 2024.
Short-Term Trend: The price is currently correcting within the uptrend, with recent candles showing potential consolidation around the $80-
Hologic: Holding Above 200-week SMA Inside of a Cup with HandleHologic is currently Consolidating within the potential handle of a Bullish Cup with Handle pattern and is holding above the 200-week Simple Moving Average. If this pattern plays out successfully, the measured move target would take HOLX up to around $118. n addition to the technical pattern, HOLX s
$HOLXNASDAQ:HOLX if they drop #Covid thingy again, testing stocks derivative of vaccines play.
Hologic was earnings winner and not only thing on its plate.
coming to gap AMEX:IHI AMEX:SPY
Hologic's (HOLX:NASDAQ) Strong Fundamentals Post-CovidHologic, a leading company in the healthcare sector, continues to display appealing business economics and robust fundamentals, even after the Covid pandemic. In this analysis, we delve into additional critical factors contributing to its attractiveness, such as positive sentiment and price studies.
$HOLX with a Bullish outlook following its earnings #Stocks The PEAD projected a bullish outlook for $HOLX after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 100%.
Hologic IncHologic Inc is a developer, manufacturer, and supplier of diagnostics products, medical imaging systems, and surgical products focused on women’s health and well-being through early detection and treatment. The stock is listed on the Nasdaq Stock Exchange. The price chart formed an 11-month-long rec
$HOLX$HOLX A couple of downgrades past few days shrugged off, looking for a pop over 55ema and 2 mth high levels/ DHR rpt may help. $IHI
HOLX - Long Period of Low Volatility Leading to Break Out HOLX has tested this upper trend line two time previously
Right now price is within a very tight range and has been that way for quite awhile
Price while in this state builds up pressure and tends to break out positively when it is ready
A third test of this upper trend line is possible
Buy HOLX1. Golden crosses, trendline broke
2. Price reversal at MA 50, and Fibo level 50
3. Expecting Wave 5 to continue
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
HOLX4588305
Hologic, Inc. 4.625% 01-FEB-2028Yield to maturity
—
Maturity date
Feb 1, 2028
HOLX4587167
Hologic, Inc. 4.625% 01-FEB-2028Yield to maturity
—
Maturity date
Feb 1, 2028
USU38284AF9
Hologic, Inc. 3.25% 15-FEB-2029Yield to maturity
—
Maturity date
Feb 15, 2029
See all HO1 bonds
Frequently Asked Questions
The current price of HO1 is 56.50 EUR — it has decreased by −0.88% in the past 24 hours. Watch Hologic, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Hologic, Inc. stocks are traded under the ticker HO1.
HO1 stock has fallen by −0.88% compared to the previous week, the month change is a −3.42% fall, over the last year Hologic, Inc. has showed a −23.65% decrease.
We've gathered analysts' opinions on Hologic, Inc. future price: according to them, HO1 price has a max estimate of 80.46 EUR and a min estimate of 55.64 EUR. Watch HO1 chart and read a more detailed Hologic, Inc. stock forecast: see what analysts think of Hologic, Inc. and suggest that you do with its stocks.
HO1 stock is 0.88% volatile and has beta coefficient of 0.00. Track Hologic, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hologic, Inc. there?
Today Hologic, Inc. has the market capitalization of 12.64 B, it has decreased by −0.56% over the last week.
Yes, you can track Hologic, Inc. financials in yearly and quarterly reports right on TradingView.
Hologic, Inc. is going to release the next earnings report on Nov 3, 2025. Keep track of upcoming events with our Earnings Calendar.
HO1 earnings for the last quarter are 0.92 EUR per share, whereas the estimation was 0.90 EUR resulting in a 1.52% surprise. The estimated earnings for the next quarter are 0.94 EUR per share. See more details about Hologic, Inc. earnings.
Hologic, Inc. revenue for the last quarter amounts to 869.11 M EUR, despite the estimated figure of 857.75 M EUR. In the next quarter, revenue is expected to reach 886.88 M EUR.
HO1 net income for the last quarter is 165.45 M EUR, while the quarter before that showed −16.08 M EUR of net income which accounts for 1.13 K% change. Track more Hologic, Inc. financial stats to get the full picture.
No, HO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has 7.06 K employees. See our rating of the largest employees — is Hologic, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hologic, Inc. EBITDA is 1.06 B EUR, and current EBITDA margin is 31.74%. See more stats in Hologic, Inc. financial statements.
Like other stocks, HO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hologic, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hologic, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hologic, Inc. stock shows the sell signal. See more of Hologic, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.